UNIVERSE PHARMACEUTICAL-CL A (UPC) Stock Income Statement
NASDAQ:UPC • KYG9442G1385
2.68 USD
-0.18 (-6.29%)
Last: Feb 17, 2026, 08:00 PM
| 2025 (2025-9-30) | 2024 (2024-9-30) | 2023 (2023-9-30) | 2022 (2022-9-30) | 2021 (2021-9-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 17.86M | 23.02M | 32.31M | 40.14M | 47.98M | |||
| Cost Of Goods | 11.56M | 16.95M | 21.99M | 18.25M | 22.66M | |||
| Gross Profit | 6.30M | 6.07M | 10.32M | 21.89M | 25.33M | |||
| Operating Expenses | 9.22M | 14.09M | 14.28M | 29.33M | 11.73M | |||
| Research and Development | 497.00K | 2.99M | 4.82M | 7.62M | 5.45M | |||
| Selling, General, and Administrative Expenses | 8.30M | 10.85M | 9.23M | 21.50M | 6.10M | |||
| Operating Income | -2.92M | -8.02M | -3.97M | -7.44M | 13.59M | |||
| Interest Income/Expense | -167.00K | -246.20K | -125.70K | -120.00K | -70.00K | |||
| Other Income/Expense | -111.00K | 141.50K | -235.70K | -420.00K | 160.00K | |||
| Non Recurring Items | -481.10K | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | -3.67M | -8.12M | -4.33M | -7.98M | 13.68M | |||
| Income Tax | 0.00 | 606.70K | 2.25M | 750.00K | 2.36M | |||
| Net Income | -3.67M | -8.73M | -6.58M | -8.74M | 11.32M | |||
| EBITDA | -2.40M | -7.53M | -3.46M | -6.91M | 14.04M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -8.05 | -626.96 | -1.09K | -1.45K | 53.67 | |||
| Statistics | ||||||||
| Gross Profit Margin | 35.28% | 26.37% | 31.93% | 54.53% | 52.79% | |||
| Profit Margin | -20.56% | -37.90% | -20.37% | -21.77% | 23.59% | |||
| Operating Profit Margin | -16.33% | -34.83% | -12.28% | -18.54% | 28.32% | |||
All data in USD